Low Dose vs High Dose GLP-1: Finding Your Sweet Spot
GLP-1 trial protocols escalate everyone to maximum dose. STEP 1 pushed all patients to semaglutide 2.4 mg. SURMOUNT-1 pushed to tirzepatide 15 mg.
Can You Lose Weight on the Lowest Dose of Semaglutide?
Yes, many people lose 3-6 pounds in the first month on 0.25mg semaglutide.
Loose Skin After GLP-1 Weight Loss: Prevention & Treatment Options
Loose skin is a near-universal consequence of significant weight loss. Bariatric surgery patients have dealt with it for decades.
LL-37: Can You Stack It with GLP-1 Medications?
No clinical trial has tested LL-37 combined with semaglutide, tirzepatide, or any other GLP-1 receptor agonist.
LL-37 What the Research Actually Says: Evidence Review
LL-37 has one of the largest research literatures of any peptide marketed in wellness contexts.
LL-37 How It Works: Mechanism of Action Explained Simply
LL-37 has more mechanism research behind it than most peptides marketed in wellness contexts.
LL-37 Dosing Protocol: Cycling, Frequency & Best Practices
LL-37 has no FDA-approved human dose for any indication.
LL-37 Complete Guide: Benefits, Dosing, Side Effects & Research
Introduction LL-37 is a 37-amino-acid antimicrobial peptide, the C-terminal fragment of the human cathelicidin antimicrobial protein (hCAP18) encoded by the CAMP gene. It’s the…
Liraglutide Switching to or From: Transition Protocols & Dose Conversion
Most patients on liraglutide eventually consider switching. The reasons vary. Daily injections get tiring compared with weekly options.
